Phenome-Wide Association Studies: Embracing Complexity for Discovery

Human Heredity

Volumn 79, Issue 3-4, 2015, Pages 111-123

  Pendergrass, Sarah A ^a   Verma, Anurag ^c   Okula, Anna ^c   Hall, Molly A ^c   Crawford, Dana C ^b   Ritchie, Marylyn D ^a,c  

^a GEISINGER HEALTH SYSTEM   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

Genome wide association studies; Phenome wide association studies; Phenomics

Indexed keywords

ARTICLE; ENVIRONMENTAL EXPOSURE; EPISTASIS; GENE INTERACTION; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC EPIDEMIOLOGY; GENETIC HETEROGENEITY; GENETIC VARIABILITY; GENOTYPE; HEREDITY; HUMAN; PHENOTYPE; PHENOTYPIC VARIATION; PLEIOTROPY; PRINCIPAL COMPONENT ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; ENVIRONMENT; GENETICS; GENOME-WIDE ASSOCIATION STUDY;

ENVIRONMENT; EPISTASIS, GENETIC; GENETIC PLEIOTROPY; GENOME-WIDE ASSOCIATION STUDY; HUMANS; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84937871974     PISSN: 00015652     EISSN: 14230062     Source Type: Journal    
DOI: 10.1159/000381851     Document Type: Article

References (161)

1. Lieberman-Aiden E, et al: Comprehensive mapping of long-range interactions reveals folding principles of the human genome. Science 2009; 326; 289-293.
2. Kellis M, et al: Defining functional DNA elements in the human genome. Proc Natl Acad Sci USA 2014; 111: 6131-6138.
3. Choudhry S, et al: Dissecting complex diseases in complex populations: asthma in Latino Americans. Proc Am Thorac Soc 2007; 4: 226-233.
4. Maher B: Personal genomes: the case of the missing heritability. Nature 2008; 456: 18-21.
5. Tyler AL, Asselbergs FW, Williams SM, Moore JH: Shadows of complexity: what biological networks reveal about epistasis and pleiotropy. Bioessays 2009; 31: 220-227.
6. Ritchie MD, Holzinger ER, Li R, Pendergrass SA, Kim D: Methods of integrating data to uncover genotype-phenotype interactions. Nat Rev Genet 2015; 16: 85-97.
7. McCarty CA, et al: Validation of PhenX measures in the personalized medicine research project for use in gene/environment studies. BMC Med Genomics 2014; 7: 3.
8. Hamilton CM, et al: The PhenX Toolkit: get the most from your measures. Am J Epidemiol 2011; 174: 253-260.
9. McCarty CA, et al: PhenX RISING: real world implementation and sharing of PhenX measures. BMC Med Genomics 2014; 7: 16.
10. Pan H, et al: Using PhenX measures to identify opportunities for cross-study analysis. Hum Mutat 2012; 33: 849-857.
11. Pendergrass SA, et al: Next-generation analysis of cataracts: determining knowledge driven gene-gene interactions using Biofilter, and gene-environment interactions using the PhenX Toolkit. Pac Symp Biocomput 2013; 147-158.
12. Hall MA, et al: Environment-wide association study (EWAS) for type 2 diabetes in the Marshfield Personalized Medicine Research Project Biobank. Pac Symp Biocomput 2014; 200-211.
13. Ellis K, et al: Identifying Active Travel Behaviors in Challenging Environments Using GPS, Accelerometers, and Machine Learning Algorithms. Front Public Health 2014; 2: 36.
14. McCrorie PR, Fenton C, Ellaway A: Combining GPS, GIS, and accelerometry to explore the physical activity and environment relationship in children and young people - a review. Int J Behav Nutr Phys Act 2014; 11: 93.
15. Burgoine T, Jones AP, Brouwer RJN, Neelon SEB: Associations between BMI and home, school and route environmental exposures estimated using GPS and GIS: do we see evidence of selective daily mobility bias in children? Int J Health Geogr 2015; 14: 8.
16. Lanktree MB, Hassell RG, Lahiry P, Hegele RA: Phenomics: expanding the role of clinical evaluation in genomic studies. J Investig Med 2010; 58: 700-706.
17. Oti M, Huynen MA, Brunner HG: Phenome connections. Trends Genet 2008; 24: 103-106.
18. Houle D, Govindaraju DR, Omholt S: Phenomics: the next challenge. Nat Rev Genet 2010; 11: 855-866.
19. Viti C, Decorosi F, Marchi E, Galardini M, Giovannetti L: High-throughput phenomics. Methods Mol Biol 2015; 1231: 99-123.
20. Ritchie MD, et al: Robust replication of genotype-phenotype associations across multiple diseases in an electronic medical record. Am J Hum Genet 2010; 86: 560-572.
21. Crawford DC, et al: eMERGEing progress in genomics-the first seven years. Front Genet 2014; 5: 184.
22. Gottesman O, et al: The Electronic Medical Records and Genomics (eMERGE) Network: past, present, and future. Genet Med 2013; 15: 761-771.
23. McCarty CA, et al: The eMERGE Network: a consortium of biorepositories linked to electronic medical records data for conducting genomic studies. BMC Med Genomics 2011; 4: 13.
24. Hays J, et al: The Women's Health Initiative recruitment methods and results. Ann Epidemiol 2003; 13:S18-S77.
25. Friedman GD, et al: CARDIA: study design, recruitment, and some characteristics of the examined subjects. J Clin Epidemiol 1988; 41: 1105-1116.
26. Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group. Control Clin Trials 1998; 19: 61-109.
27. Fried LP, et al: The Cardiovascular Health Study: design and rationale. Ann Epidemiol 1991; 1: 263-276.
28. Kolonel LN, Altshuler D, Henderson BE: The multiethnic cohort study: exploring genes, lifestyle and cancer risk. Nat Rev Cancer 2004; 4: 519-527.
29. Bild DE, et al: Multi-ethnic study of atherosclerosis: objectives and design. Am J Epidemiol 2002; 156: 871-881.
30. Goodpaster BH, et al: Attenuation of skeletal muscle and strength in the elderly: the Health ABC Study. J Appl Physiol 2001; 90: 2157-2165.
31. Signorello LB, Hargreaves MK, Blot WJ: The Southern Community Cohort Study: investigating health disparities. J Health Care Poor Underserved 2010; 21: 26-37.
32. Taylor HA: The Jackson Heart Study: an overview. Ethn Dis 2005; 15:S6-1-S6-3.
33. Sorlie PD, et al: Design and implementation of the Hispanic Community Health Study/Study of Latinos. Ann Epidemiol 2010; 20: 629-641.
34. Hofman A, et al: The Rotterdam Study: 2014 objectives and design update. Eur J Epidemiol 2013; 28: 889-926.
35. Splansky GL, et al: The Third Generation Cohort of the National Heart, Lung, and Blood Institute's Framingham Heart Study: design, recruitment, and initial examination. Am J Epidemiol 2007; 165: 1328-1335.
36. Tatonetti NP, Ye PP, Daneshjou R, Altman RB: Data-driven prediction of drug effects and interactions. Sci Transl Med 2012; 4: 125ra31.
37. Fitzmaurice GM, Laird NM, Ware JH: Applied Longitudinal Analysis. Hoboken, John Wiley & Sons, 2012.
38. Sitlani CM, et al: Generalized estimating equations for genome-wide association studies using longitudinal phenotype data. Stat Med 2015; 34: 118-130.
39. Kerem B, Kerem E: The molecular basis for disease variability in cystic fibrosis. Eur J Hum Genet 1996; 4: 65-73.
40. Chandriani S, et al: A core MYC gene expression signature is prominent in basal-like breast cancer but only partially overlaps the core serum response. PLoS One 2009; 4:e6693.
41. Pendergrass SA, et al: Limited systemic sclerosis patients with pulmonary arterial hypertension show biomarkers of inflammation and vascular injury. PLoS One 2010; 5:e12106.
42. Pendergrass SA, et al: Intrinsic gene expression subsets of diffuse cutaneous systemic sclerosis are stable in serial skin biopsies. J Investig Dermatol 2012; 132: 1363-1373.
43. Milano A, et al: Molecular subsets in the gene expression signatures of scleroderma skin. PLoS One 2008; 3:e2696.
44. Haldar P, et al: Cluster Analysis and Clinical Asthma Phenotypes. Am J Respir Crit Care Med 2008; 178: 218-224.
45. Wardlaw AJ, Silverman M, Siva R, Pavord ID, Green R: Multi-dimensional phenotyping: towards a new taxonomy for airway disease. Clin Exp Allergy 2005; 35: 1254-1262.
46. Lahiry P, et al: A multiplex human syndrome implicates a key role for intestinal cell kinase in development of central nervous, skeletal, and endocrine systems. Am J Hum Genet 2009; 84: 134-147.
47. Aschard H, et al: Maximizing the power of principal-component analysis of correlated phenotypes in genome-wide association studies. Am J Hum Genet 2014; 94: 662-676.
48. Van der Sluis S, Posthuma D, Dolan CV: TATES: Efficient Multivariate genotype-phenotype analysis for genome-wide association studies. PLoS Genet 2013; 9:e1003235.
49. Kim S, Sohn K-A, Xing EP: A multivariate regression approach to association analysis of a quantitative trait network. Bioinformatics 2009; 25:i204-i212.
50. Hwang T, et al: Co-clustering phenome - genome for phenotype classification and disease gene discovery. Nucleic Acids Res 2012; 40:e146.
51. Dettling M, Bühlmann P: Supervised clustering of genes. Genome Biol 2002; 3:research- 0069-research0069.15.
52. D'haeseleer P: How does gene expression clustering work? Nat Biotech 2005; 23: 1499-1501.
53. Burgel PR, Paillasseur JL, Roche N: Identification of clinical phenotypes using cluster analyses in COPD patients with multiple comorbidities. Bio Med Res Int 2014; 2014: 420134.
54. Roque FS, et al: Using electronic patient records to discover disease correlations and stratify patient cohorts. PLoS Comput Biol 2011; 7:e1002141.
55. Moore WC, et al: Sputum neutrophil counts are associated with more severe asthma phenotypes using cluster analysis. J Allergy Clin Immunol 2014; 133: 1557-1563.e5.
56. Kidd BA, Peters LA, Schadt EE, Dudley JT: Unifying immunology with informatics and multiscale biology. Nat Immunol 2014; 15: 118-127.
57. Goh K-I, et al: The human disease network. Proc Natl Acad Sci USA 2007; 104: 8685-8690.
58. Goh K-I, Choi I-G: Exploring the human diseasome: the human disease network. Brief Funct Genomics 2012; 11: 533-542.
59. Darabos C, et al: The multiscale backbone of the human phenotype network based on biological pathways. BioData Min 2014; 7: 1.
60. Darabos C, Harmon SH, Moore JH: Using the bipartite human phenotype network to reveal pleiotropy and epistasis beyond the gene. Pac Symp Biocomput 2014;188-199.
61. Wagner GP, Zhang J: The pleiotropic structure of the genotype-phenotype map: the evolvability of complex organisms. Nat Rev Genet 2011; 12: 204-213.
62. Solovieff N, Cotsapas C, Lee PH, Purcell SM, Smoller JW: Pleiotropy in complex traits: challenges and strategies. Nat Rev Genet 2013; 14: 483-495.
63. Tyler AL, Crawford DC, Pendergrass SA: The detection and characterization of pleiotropy: discovery, progress, and promise. Brief Bioinform, in press.
64. Paaby AB, Rockman MV: The many faces of pleiotropy. Trends Genet 2013; 29: 66-73.
65. Corder EH, et al: The apolipoprotein E E4 allele and sex-specific risk of Alzheimer's disease. JAMA 1995; 273: 373-374.
66. Sing CF, Davignon J: Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation. Am J Hum Genet 1985; 37: 268-285.
67. Zhernakova A, van Diemen CC, Wijmenga C: Detecting shared pathogenesis from the shared genetics of immune-related diseases. Nat Rev Genet 2009; 10: 43-55.
68. Huang W, Wang P, Liu Z, Zhang L: Identifying disease associations via genome-wide association studies. BMC Bioinformatics 2009; 10(suppl 1):S68.
69. Lees CW, Barrett JC, Parkes M, Satsangi J: New IBD genetics: common pathways with other diseases. Gut 2011; 60: 1739-1753.
70. Pierce BL, Ahsan H: Genome-wide 'pleiotropy scan' identifies HNF1A region as a novel pancreatic cancer susceptibility locus. Cancer Res 2011; 71: 4352-4358.
71. Voight BF, et al: Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet 2010; 42: 579-589.
72. Huang J, Johnson AD, O'Donnell CJ: PRIMe: a method for characterization and evaluation of pleiotropic regions from multiple genomewide association studies. Bioinformatics 2011; 27: 1201-1206.
73. Okada Y, et al: Genome-wide association study for C-reactive protein levels identified pleiotropic associations in the IL6 locus. Hum Mol Genet 2011; 20: 1224-1231.
74. Hindorff LA, et al: Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci USA 2009; 106: 9362-9367.
75. Sivakumaran S, et al: Abundant pleiotropy in human complex diseases and traits. Am J Hum Genet 2011; 89: 607-618.
76. Romeo G, McKusick VA: Phenotypic diversity, allelic series and modifier genes. Nat Genet 1994; 7: 451-453.
77. Gamazon ER, et al: SCAN: SNP and copy number annotation. Bioinformatics 2010; 26: 259-262.
78. Moore CB, Wallace JR, Frase AT, Pendergrass SA, Ritchie MD: BioBin: a bioinformatics tool for automating the binning of rare variants using publicly available biological knowledge. BMC Med Genomics 2013; 6(suppl 2):S6.
79. Ionita-Laza I, Lee S, Makarov V, Buxbaum JD, Lin X: Sequence kernel association tests for the combined effect of rare and common variants. Am J Hum Genet 2013; 92: 841-853.
80. Wu MC, et al: Rare-variant association testing for sequencing data with the sequence kernel association test. Am J Hum Genet 2011; 89: 82-93.
81. Redon R, et al: Global variation in copy number in the human genome. Nature 2006; 444: 444-454.
82. Coe BP, Girirajan S, Eichler EE: The genetic variability and commonality of neurodevelopmental disease. Am J Med Genet C Semin Med Genet 2012; 160C:118-129.
83. Girirajan S, et al: Relative burden of large CNVs on a range of neurodevelopmental phenotypes. PLoS Genet 2011; 7:e1002334.
84. Girirajan S, et al: Global increases in both common and rare copy number load associated with autism. Hum Mol Genet 2013; 22: 2870-2880.
85. De Visser JAGM, Cooper TF, Elena SF: The causes of epistasis. Proc Biol Sci 2011; 278: 3617-3624.
86. Turner SD, et al: Knowledge-driven multi-locus analysis reveals gene-gene interactions influencing HDL cholesterol level in two independent EMR-linked biobanks. PLoS One 2011; 6:e19586.
87. Bush WS, et al: A knowledge-driven interaction analysis reveals potential neurodegenerative mechanism of multiple sclerosis susceptibility. Genes Immun 2011; 12: 335-340.
88. Pendergrass SA, et al: Genomic analyses with biofilter 2.0: knowledge driven filtering, annotation, and model development. Bio-Data Mining 2013; 6: 25.
89. Bush WS, Dudek SM, Ritchie MD: Biofilter: a knowledge-integration system for the multi-locus analysis of genome-wide association studies. Pac Symp Biocomput 2009; 368-379.
90. Hu T, Darabos C, Cricco ME, Kong E, Moore JH: Genome-wide genetic interaction analysis of glaucoma using expert knowledge derived from human phenotype networks. Pac Symp Biocomput 2015; 20: 207-218.
91. Pan Q, Hu T, Moore JH: Epistasis, complexity, and multifactor dimensionality reduction. Methods Mol Biol 2013; 1019: 465-477.
92. Ritchie MD, et al: Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. Am J Hum Genet 2001; 69: 138-147.
93. Holzinger ER, Dudek SM, Frase AT, Pendergrass SA, Ritchie MD: ATHENA: the analysis tool for heritable and environmental network associations. Bioinformatics 2014; 30: 698-705.
94. Holzinger ER, et al: ATHENA: a tool for meta-dimensional analysis applied to genotypes and gene expression data to predict HDL cholesterol levels. Pac Symp Biocomput 2013;385-396.
95. Turner SD, Dudek SM, Ritchie MD: ATHENA: a knowledge-based hybrid backpropagation-grammatical evolution neural network algorithm for discovering epistasis among quantitative trait Loci. BioData Mining 2010; 3: 5.
96. Beam AL, Motsinger-Reif A, Doyle J: Bayesian neural networks for detecting epistasis in genetic association studies. BMC Bioinformatics 2014; 15: 368.
97. Ritchie MD: Finding the epistasis needles in the genome-wide haystack. Methods Mol Biol 2015; 1253: 19-33.
98. Liu C, Ma J, Amos CI: Bayesian variable selection for hierarchical gene-environment and gene-gene interactions. Hum Genet 2015; 134: 23-36.
99. Curk T, Rot G, Zupan B: SNPsyn: detection and exploration of SNP-SNP interactions. Nucleic Acids Res 2011; 39:W444-W449.
100. Tyler AL, Lu W, Hendrick JJ, Philip VM, Carter GW: CAPE: an R package for combined analysis of pleiotropy and epistasis. PLoS Comput Biol 2013; 9:e1003270.
101. Philip VM, Tyler AL, Carter GW: Dissection of complex gene expression using the combined analysis of pleiotropy and epistasis. Pac Symp Biocomput 2014;200-211.
102. Tyler AL, McGarr TC, Beyer BJ, Frankel WN, Carter GW: A genetic interaction network model of a complex neurological disease. Genes Brain Behav 2014; 13: 831-840.
103. Holzinger ER, Ritchie MD: Integrating heterogeneous high-throughput data for metadimensional pharmacogenomics and disease-related studies. Pharmacogenomics 2012; 13: 213-222.
104. Pendergrass SA, et al: The use of phenomewide association studies (PheWAS) for exploration of novel genotype-phenotype relationships and pleiotropy discovery. Genet Epidemiol 2011; 35: 410-422.
105. Pendergrass SA, Ritchie MD: Phenomewide association studies: leveraging comprehensive phenotypic and genotypic data for discovery. Curr Genet Med Rep, in press.
106. Pendergrass SA, et al: Phenome-wide association study (PheWAS) for detection of pleiotropy within the Population Architecture using Genomics and Epidemiology (PAGE) Network. PLoS Genet 2013; 9: e1003087.
107. Hall MA, et al: Detection of pleiotropy through a Phenome-wide association study (PheWAS) of epidemiologic data as part of the Environmental Architecture for Genes Linked to Environment (EAGLE) study. PLoS Genet 2014; 10:e1004678.
108. Denny JC; et al: PheWAS: demonstrating the feasibility of a phenome-wide scan to discover gene-disease associations. Bioinformatics 2010; 26: 1205-1210.
109. Hebbring SJ, et al: A PheWAS approach in studying HLA-DRB1 ∗ 1501. Genes Immun 2013; 14: 187-191.
110. Namjou B, et al: Phenome-wide association study (PheWAS) in EMR-linked pediatric cohorts, genetically links PLCL1 to speech language development and IL5-IL13 to eosinophilic esophagitis. Front Genet 2014; 5: 401.
111. Denny JC, et al: Systematic comparison of phenome-wide association study of electronic medical record data and genomewide association study data. Nat Biotechnol 2013; 31: 1102-1110.
112. Verma A, et al: Exploring the relationship between immune system related genetic variants and complex traits and disease through a phenome-wide association study (PheWAS). Submitted.
113. Moore CB, et al: Phenome-wide association study relating pretreatment laboratory parameters with human genetic variants in AIDS clinical trials group protocols. Open Forum Infect Dis 2015;2:ofu113.
114. Pendergrass SA, et al: An investigation of pleiotropy using PheWAS in African Americans in the population architecture using genomics and epidemiology (PAGE) network. Submitted.
115. Tryka KA, et al: NCBI's database of genotypes and phenotypes: dbGaP. Nucleic Acids Res 2014; 42:D975-D979.
116. Evangelou E, Ioannidis JPA: Meta-analysis methods for genome-wide association studies and beyond. Nat Rev Genet 2013; 14: 379-389.
117. Moore CB, Wallace JR, Frase AT, Pendergrass SA, Ritchie MD: Using biobin to explore rare variant population stratification. Pac Symp Biocomput 2013;332-343.
118. Bansal V, Libiger O, Torkamani A, Schork NJ: Statistical analysis strategies for association studies involving rare variants. Nat Rev Genet 2010; 11: 773-785.
119. Mitchell SL, et al: Investigating the relationship between mitochondrial genetic variation and cardiovascular-related traits to develop a framework for mitochondrial phenome-wide association studies. Bio Data Min 2014; 7: 6.
120. Dumitrescu L, et al: Towards a phenomewide catalog of human clinical traits impacted by genetic ancestry. Submitted.
121. Neuraz A, et al: Phenome-wide association studies on a quantitative trait: application to TPMT enzyme activity and thiopurine therapy in pharmacogenomics. PLoS Comput Biol 2013; 9:e1003405.
122. Kim S, Xing EP: Statistical estimation of correlated genome associations to a quantitative trait network. PLoS Genet 2009; 5: e1000587.
123. O'Reilly PF, et al: Multi Phen: Joint model of multiple phenotypes can increase discovery in GWAS. PLoS One 2012; 7:e34861.
124. Pendergrass SA, Dudek SM, Crawford DC, Ritchie MD: Synthesis-View: visualization and interpretation of SNP association results for multi-cohort, multi-phenotype data and meta-analysis. BioData Min 2010; 3: 10.
125. Pendergrass S, Dudek SM, Roden DM, Crawford DC, Ritchie MD: Visual integration of results from a large DNA biobank (BioVU) using synthesis-view. Pac Symp Biocomput 2011;265-275.
126. Pendergrass SA, Dudek SM, Crawford DC, Ritchie MD: Visually integrating and exploring high throughput Phenome-Wide Association Study (PheWAS) results using PheWAS-View. BioData Min 2012; 5: 5.
127. Wolfe D, Dudek S, Ritchie MD, Pendergrass SA: Visualizing genomic information across chromosomes with Pheno Gram. BioData Min 2013; 6: 18.
128. R Development Core Team: R: A Language and Environment for Statistical Computing. 2008. http://www.R-project.org.
129. Wickham H: ggplot2: elegant graphics for data analysis. New York, Springer.
130. Kanehisa M, Goto S: KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res 2000; 28: 27-30.
131. Cline MS, et al: Integration of biological networks and gene expression data using Cytoscape. Nat Protocols 2007; 2: 2366-2382.
132. Saito R, et al: A travel guide to Cytoscape plugins. Nat Methods 2012; 9: 1069-1076.
133. Wang K, Li M, Hakonarson H: Analysing biological pathways in genome-wide association studies. Nat Rev Genet 2010; 11: 843-854.
134. Yaspan BL, et al: Genetic analysis of biological pathway data through genomic randomization. Hum Genet 2011; 129: 563-571.
135. Williams SM, Haines JL: Correcting away the hidden heritability. Ann Hum Genet 2011; 75: 348-350.
136. Shelton JF, Tancredi DJ, Hertz-Picciotto I: Independent and dependent contributions of advanced maternal and paternal ages to autism risk. Autism Res 2010; 3: 30-39.
137. Durkin MS. et al: Advanced parental age and the risk of autism spectrum disorder. Am J Epidemiol 2008; 168: 1268-1276.
138. Cheslack-Postava K, Liu K, Bearman PS: Closely spaced pregnancies are associated with increased odds of autism in California sibling births. Pediatrics 2011; 127: 246-253.
139. Beard CM, Panser LA, Katusic SK: Is excess folic acid supplementation a risk factor for autism? Med Hypotheses 2011; 77: 15-17.
140. Schmidt RJ, et al: Prenatal vitamins, onecarbon metabolism gene variants, and risk for autism. Epidemiology 2011; 22: 476-485.
141. Croen LA, Grether JK, Yoshida CK, Odouli R, Hendrick V: Antidepressant use during pregnancy and childhood autism spectrum disorders. Arch Gen Psychiatry 2011; 68: 1104-1112.
142. Gardener H, Spiegelman D, Buka SL: Perinatal and neonatal risk factors for autism: a comprehensive meta-analysis. Pediatrics 2011; 128: 344-355.
143. Hultman CM, Sandin S, Levine SZ, Lichtenstein P, Reichenberg A: Advancing paternal age and risk of autism: new evidence from a population-based study and a meta-analysis of epidemiological studies. Mol Psychiatry 2011; 16: 1203-1212.
144. Larsson M, Weiss B, Janson S, Sundell J, Bornehag C-G: Associations between indoor environmental factors and parentalreported autistic spectrum disorders in children 6-8 years of age. Neurotoxicology 2009; 30: 822-831.
145. Lyall K, Pauls DL, Santangelo S, Spiegelman D, Ascherio A: Maternal early life factors associated with hormone levels and the risk of having a child with an autism spectrum disorder in the nurses health study II. J Autism Dev Disord 2011; 41: 618-627.
146. Roberts EM, et al: Maternal residence near agricultural pesticide applications and autism spectrum disorders among children in the California Central Valley. Environ Health Perspect 2007; 115: 1482-1489.
147. Mitchell MM, et al: Levels of select PCB and PBDE congeners in human postmortem brain reveal possible environmental involvement in 15q11-q13 duplication autism spectrum disorder. Environ Mol Mutagen 2012; 53: 589-598.
148. Hertz-Picciotto I, et al: Polybrominated diphenyl ethers in relation to autism and developmental delay: a case-control study. Environ Health 2011; 10: 1.
149. Volk HE, Hertz-Picciotto I, Delwiche L, Lurmann F, McConnell R: Residential proximity to freeways and autism in the CHARGE study. Environ Health Perspect 2011; 119: 873-877.
150. Volk HE, Lurmann F, Penfold B, Hertz-Picciotto I, McConnell R: Traffic-related air pollution, particulate matter, and autism. JAMA Psychiatry 2013; 70: 71-77.
151. Becerra TA, Wilhelm M, Olsen J, Cockburn M, Ritz B: Ambient air pollution and autism in Los Angeles County, California. Environ Health Perspect 2013; 121: 380-386.
152. Windham GC, Zhang L, Gunier R, Croen LA, Grether JK: Autism spectrum disorders in relation to distribution of hazardous air pollutants in the San Francisco bay area. Environ Health Perspect 2006; 114: 1438-1444.
153. Kalkbrenner AE, et al: Perinatal exposure to hazardous air pollutants and autism spectrum disorders at age 8. Epidemiology 2010; 21: 631-641.
154. Roberts AL, et al: Perinatal air pollutant exposures and autism spectrum disorder in the children of Nurses' Health Study II participants. Environ Health Perspect 2013; 121: 978-984.
155. Marcellus Shale Research Initiative. http://www.geisinger.org/100/pdf/Marcellus-Shale-Research-Case-for-Support-2013.pdf.
156. Hertz-Picciotto I, et al: The CHARGE Study: an epidemiologic investigation of genetic and environmental factors contributing to autism. Environ Health Perspect 2006; 114: 1119-1125.
157. Patel CJ, Bhattacharya J, Butte AJ: An environment-wide association study (EWAS) on type 2 diabetes mellitus. PLoS One 2010; 5:e10746.
158. Patel CJ, et al: Investigation of maternal environmental exposures in association with self-reported preterm birth. Reprod Toxicol 2013; 45C:1-7.
159. Patel CJ, Cullen MR, Ioannidis JPA, Butte AJ: Systematic evaluation of environmental factors: persistent pollutants and nutrients correlated with serum lipid levels. Int J Epidemiol 2012; 41: 828-843.
160. Tzoulaki I, et al: A nutrient-wide association study on blood pressure. Circulation 2012; 126: 2456-2464.
161. Davis MA, et al: A dietary-wide association study (DWAS) of environmental metal exposure in US children and adults. PLoS One 2014; 9:e104768.